Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02)
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Dense Therapy in Aggressive Lymphoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma.
- Status
- TERMINATED
- Phase
- PHASE2
A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
RTA 744 Injection in Patients With Leptomeningeal Disease
- Status
- TERMINATED
- Phase
- PHASE1
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
- Status
- COMPLETED
- Phase
- N/A
Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Nutritional Assessment Intervention to Improve Cancer-Related Fatigue
- Status
- COMPLETED
- Phase
- NA
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)
- Status
- TERMINATED
- Phase
- PHASE2
Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2